GynecologyGynecologyГинекология2079-56962079-5831Consilium Medicum28005ArticlesСтатьиResearch ArticleProblemy bezopasnosti primeneniya lekarstvennykh sredstv pri infektsiyakh u beremennykh zhenshchinПроблемы безопасности применения лекарственных средств при инфекциях у беременных женщинUshkalovaE AУшкаловаЕ А

Кафедра общей и клинической фармакологии

РУДН15022009111VOL 11, NO1 (2009)ТОМ 11, №1 (2009)717509042020Copyright ©; 2009, Consilium MedicumCopyright ©; 2009, ООО "Консилиум Медикум"2009Consilium MedicumООО "Консилиум Медикум"https://creativecommons.org/licenses/by-nc-sa/4.0https://gynecology.orscience.ru/2079-5831/article/view/28005

Использование лекарственных средств (ЛС) при беременности продолжает оставаться од-ной из самых противоречивых и плохо изученных проблем медицины. Это обусловлено, прежде всего, невозможностью проведения в силу этических причин крупномасштабных рандомизированных исследований с участием беременных женщин. Основным источником данных о безопасности ЛС в период гестации являются фармакоэпидемиологические исследования. Наряду с ретроспективными фармакоэпидемиологическими исследованиями в последние годы стали проводиться и проспективные исследования. Это, прежде всего, регистры беременности, направленные на выявление женщин, принимающих определенные ЛС, и регистрацию исходов беременностей у них. Сначала регистры беременности вели производители оригинальных препаратов, впоследствии во многих странах были введены национальные регистры беременности.

Brent R.L. Environmental Causes of Human Congenital Malformations: The Pediatrician’s Role in Dealing With These Complex Clinical Problems Caused by a Multiplicity of Environmental and Genetic Factors. PEDIATRICS 2004; 113 (4): 957–68.Wilson J.G. Current status of teratology. In: Wilson J.G, Fraser F.C, eds. Handbook of teratology. New York: Plenum, 1977; 47.Mortensen M.E, Sever L.E, Oakley G.P. Teratology and the epidemiology of birth defects. In: Gabbe S.G, Niebyl J.R, Simpson J.L (eds): Obstetrics: Normal and Problem Pregnancies. New York, Churchill Livingstone, 1991; 233–68.Стриженок Е.А., Гудков И.В., Страчунский Л.С. Применение лекарственных средств при беременности: результаты многоцентрового фармакоэпидемиологического исследования. КМАХ. 2007; 9(2): 162–75.Amann U, Egen-Lappe V, Strunz-Lehner C, Hasford J. Antibiotics in pregnancy: analysis of potential risks and determinants in a large German statutory sickness fund population. Pharmacoepidemiol Drug Saf 2006; 15:327–37.Miller E.M. Changes in serum immunity during pregnancy. Am J Hum Biol 2009; 2.Cartin-Ceba R, Gajic O, Iyer V.N, Vlahakis N.E. Fetal outcomes of critically ill pregnant women admitted to the intensive care unit for nonobstetric causes. Crit Care Med 2008; 36 (10): 2746–51.Mann J.R, Mc Dermott S, Bao H, Bersabe A. Maternal genitourinary infection and risk of cerebral palsy. Dev Med Child Neurol 2009 Jan 26.Herr?iz M.A, Hern?ndez A, Asenjo E, Herr?iz I [Urinary tract infection in pregnancy]. Enferm Infecc Microbiol Clin 2005;23 (Suppl. 4): 40–6.Никонов А.П., Асцатурова О.Р., Шулутко П.А., Каптильный В.А. Инфекции мочевыводящих путей и беременность: диагностика и антибактериальная терапия. Consilium Medicum 2006; 6.Conde-Agudelo A, Villar J, Lindheimer M. Maternal infection and risk of preeclampsia: systematic review and metaanalysis. Am J Obstet Gyn 2008; 198 (1): 7–2.Kirkham C, Harris S, Grzybowski S. Evidence - based prenatal care: part II. Third - trimester care and prevention of infectious diseases. Am Fam Physician 2005; 71 (8): 1555–60.Swadpanich U, Lumbiganon P, Prasertcharoensook W, Laopaiboon M. Antenatal lower genital tract infection screening and treatment programs for preventing preterm delivery. Cochrane Database Syst Rev. 2008; 2: CD00617.Amann U, Egen-Lappe V, Strunz-Lehner C, Hasford J. Antibiotics in pregnancy: analysis of potential risks and determinants in a large German statutory sickness fund population. Pharmacoepidemiol Drug Saf 2006; 15:327–37.Рафальский В.В. Обоснование выбора антимикробных препаратов при амбулаторных инфекциях мочевыводящих путей. Дис. ... докт. мед. наук. Смоленск, 2004.Gagne J.J, Maio V, Berghella V et al. Prescription drug use during pregnancy: a population - based study in Regione Emilia-Romagna, Italy. Eur J Clin Pharmacol 2008; 64 (11): 1125–32.Morency A.M, Bujold E. The effect of second - trimester antibiotic therapy on the rate of preterm birth. J Obstet Gyn Can 2007; 29 (1): 35–44.Rosental M. How safe is that antimicrobial you are writing for the female patient? Infectious disease news. September 2003.Haas A, Maschmeyer G. [Antibiotic therapy in pregnancy]. Dtsch Med Wochenschr 2008; 133 (11): 511–5.Nahum G.G, Uhl K, Kennedy D.L. Antibiotic use in pregnancy and lactation: what is and is not known about teratogenic and toxic risks. Obstet Gyn 2006; 107 (5): 1120–38.Jepsen P, Skriver M.V, Floyd A et al. A population - based study of maternal use of amoxicillin and pregnancy outcome in Denmark. Br J Clin Pharmacol 2003; 55 (2): 216–21.Berkovitch M, Diav-Citrin O, Greenberg R.C et al. First - trimester exposure to amoxycillin/clavulanic acid: a prospective, controlled study. Br J Clin Pharmacol 2004; 58 (3): 298–302.Kenyon S, Pike K, Jones D.R et al. Childhood outcomes after prescription of antibiotics to pregnant women with spontaneous preterm labour: 7-year follow - up of the ORACLE II trial. Lancet 2008; 372 (9646): 1319–27.K?ll?n B.A, Otterblad Olausson P, Danielsson B.R. Iserythromycin therapy teratogenic in humans? Reprod Toxicol 2005; 20 (2): 209–14.Czeizel A.E, Rockenbauer M, Olsen J, Sоrensen H.T. A case - control teratological study of spiramycin, roxithromycin, oleandomycin and josamycin. Acta Obstet Gyn Scand 2000; 79 (3): 234–7.Pitsouni E, Iavazzo C, Athanasiou S, Falagas M.E. Single - dose azithromycin versus erythromycin or amoxicillin for Chlamydia trachomatis infection during pregnancy: a meta - analysis of randomised controlled trials. Int J Antimicrob Agents 2007; 30 (3): 213–21.European STD Guidelines, International J of STD AIDS 2001; 12 (Suppl. 3).Российское общество акушеров - гинекологов. Информационное письмо. М., Январь 2005.Sarkar M, Woodland C, Koren G, Einarson A.R. Pregnancy outcome following gestational exposure to azithromycin. BMC Pregnancy Childbirth 2006; 6: 18.Einarson A, Phillips E, Mawji F et al. A prospective controlled multicentre study of clarithromycin in pregnancy. Am J Perinatol 1998; 15 (9): 523–5.Guay D.R. Contemporary management of uncomplicated urinary tract infections. Drugs 2008; 68 (9):1169–205.Garau J. Other antimicrobials of interest in the era of extended - spectrum beta - lactamases: fosfomycin, nitrofurantoin and tigecycline. Clin Microbiol Infect 2008; 14 (Suppl. 1): 198–202.Bayrak O, Cimentepe E, Inegоl I et al. Is single - dose fosfomycin trometamol a good alternative for asymptomatic bacteriuria in the second trimesterof pregnancy? Int Urogynecol J Pelvic Floor Dysfunct 2007; 18 (5):525–9.Naber K.G, Schito G, Botto H et al. Surveillance study in Europe and Brazil on clinical aspects and Antimicrobial Resistance Epidemiology in Females with Cystitis (ARESC): implications for empiric therapy. Eur Urol 2008; 54 (5): 1164–75.Синякова Л.А., Косова И.В. Применение фосфомицина трометамола в лечении инфекций нижних отделов мочевыводящих путей. Клин. микробиол. и антимикроб. xимиотер. 2005; 7 (2).Reeves D.S. Treatment of bacteriuria in pregnancy with single dose fosfomycin trometamol: a review. Infection 1992; 20 (Suppl. 4): S313–6.Smet P.A. Clinical risk management of herb - drug interactions. Br J Clin Pharmacol 2007; 63 (3):258–67.Boullata J.I, Nace А. Safety Issues with Herbal Medicine. Pharmacotherapy 2000; 20 (3): 257–69.Low Dog T. The use of botanicals during pregnancy and lactation. Altern Ther Health Med 2009; 15 (1):54–8.Monitoring of herbal medicines http://www.whoumc.org/DynPage.aspx?id=13120&mn=1510#herbalGabardi S, Munz K, Ulbricht C. A review of dietary supplement - induced renal dysfunction. Clin J Am Soc Nephrol 2007; 2 (4): 757–65.Lai R.S, Chiang A.A, Wu M.T et al. Outbreak of bronchiolitis obliterans associated with consumption of Sauropus androgynus in Taiwan. Lancet 1996; 348: 83–5.